- 13. Cash and cash equivalents
- 14. Trade accounts receivable
- 15. Inventories
- 16. Other current and non-current assets
- 17. Property, plant and equipment
- 18. Goodwill and other intangible assets
- 19. Other accrued expenses
- 20. Other liabilities
- 21. Debt and capital lease obligations
- 22. Senior Notes
- 23. Mandatory Exchangeable Bonds
- 24. Trust preferred securities
- 25. Pensions and similar obligations
- 26. Noncontrolling interest
- 27. Fresenius SE & Co. KGaA shareholders’ equity
- 28. Other comprehensive income (loss)
26. Noncontrolling interest
NONCONTROLLING INTEREST SUBJECT TO PUT PROVISIONS
The Fresenius Group has potential obligations to purchase the noncontrolling interests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners’ discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Fresenius Group would be required to purchase all or part of third-party owners’ noncontrolling interests at the appraised fair value at the time of exercise.
As of December 31, 2011 and 2010 the Fresenius Group’s potential obligations under these put options were €317 million and €209 million, respectively, of which, at December 31, 2011, €88 million were exercisable.
NONCONTROLLING INTEREST NOT SUBJECT TO PUT PROVISIONS
As of December 31, noncontrolling interest not subject to put provisions in the Group was as follows:
€ in millions | 2011 | 2010 |
---|---|---|
Noncontrolling interest not subject to put provisions in Fresenius Medical Care AG & Co. KGaA | 4,254 | 3,574 |
Noncontrolling interest not subject to put provisions in HELIOS Kliniken GmbH | 0 | 4 |
Noncontrolling interest not subject to put provisions in VAMED AG | 28 | 23 |
Noncontrolling interest not subject to put provisions in the business segments | ||
Fresenius Medical Care | 123 | 110 |
Fresenius Kabi | 63 | 46 |
Fresenius Helios | 136 | 119 |
Fresenius Vamed | 2 | 3 |
Total noncontrolling interest not subject to put provisions | 4,606 | 3,879 |
Due to the maturity of the Mandatory Exchangeable Bonds on August 14, 2011, Fresenius SE & Co. KGaA’s shareholding in Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA) was reduced by 15,722,644 ordinary shares to 30.4% of the ordinary share capital. In November and December 2011, Fresenius SE & Co. KGaA purchased 1,399,996 ordinary shares of FMC-AG & Co. KGaA. Therewith, Fresenius SE & Co. KGaA’s shareholding in FMC-AG & Co. KGaA amounted to 30.74% of the ordinary share capital at December 31, 2011.
Noncontrolling interest not subject to put provisions changed as follows:
€ in millions | 2011 |
---|---|
Noncontrolling interest not subject to put provisions at December 31, 2010 | 3,879 |
Noncontrolling interest not subject to put provisions in profit | 605 |
Maturity of the Mandatory Exchangeable Bonds | 298 |
Dividend payments | -192 |
Purchase of ordinary shares of FMC-AG & Co. KGaA | -28 |
Stock options, currency effects and first-time consolidations | 44 |
Noncontrolling interest not subject to put provisions at December 31, 2011 | 4,606 |
25. Pensions and similar obligations
27. Fresenius SE & Co. KGaA shareholders’ equity